Clinical trial
Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis
NCT00359853 · Hospital Clinic of Barcelona, Other · Completed
Key facts
| NCT number | NCT00359853 |
|---|---|
| Title | Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis |
| Official title | Randomized Double-Blid Placebo Controlled Trial Assessing Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis In Advanced Cirrhosis |
| Lead sponsor | Hospital Clinic of Barcelona, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Spontaneous Bacterial Peritonitis, Hepatorenal Syndrome, Cirrhosis |
| Intervention type | Drug |
| Interventions | Oral norfloxacin |
| Enrollment | 70 |
| Start date | Sep 1, 2000 |
| Completion | Mar 1, 2005 |
| First posted | Aug 3, 2006 |
| Last update posted | Aug 3, 2006 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: